![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Massachusetts General Hospital |
---|---|
Information provided by: | Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT00869479 |
The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that there will be difference between subjects with NSF and other skin conditions and normal skin.
Condition |
---|
Nephrogenic Systemic Fibrosis |
Study Type: | Observational |
Study Design: | Cross-Sectional |
Official Title: | Validation of a Questionnaire as a Screening Tool to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis |
Estimated Enrollment: | 60 |
Study Start Date: | March 2009 |
Estimated Study Completion Date: | October 2009 |
Estimated Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1
subjects with a histologically-proven diagnosis of NSF
|
2
subjects with other fibrosing skin diseases
|
3
subjects with non-fibrosing skin diseases
|
4
subjects without skin diseases
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Massachusetts General Hospital Dermatology and Rheumatology clinics
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |
Massachusetts General Hospital | |
Boston, Massachusetts, United States, 02114 |
Principal Investigator: | Jonathan Kay, MD | Massachusetts General Hospital |
Responsible Party: | Massachusetts General Hospital ( Jonathan Kay, MD ) |
Study ID Numbers: | 2008P002371 |
Study First Received: | March 17, 2009 |
Last Updated: | March 25, 2009 |
ClinicalTrials.gov Identifier: | NCT00869479 History of Changes |
Health Authority: | United States: Institutional Review Board |
Nephrogenic Systemic Fibrosis Screening |
Signs and Symptoms Fibrosis Nephrogenic Systemic Fibrosis |
Signs and Symptoms Pathologic Processes Fibrosis |